Otsuka Pharmaceutical & Science 37 Collaborate To Advance Digital Health Innovation

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Science 37 recently announced that they are collaborating to advance digital health innovation, focusing on technology-enabled clinical trials at home. More specifically, the two companies plan to focus on the areas of psychiatry and behavioral health by further digitizing Otsuka’s mobile clinical study protocols.

Statements about the collaboration from Otsuka have emphasized their commitment to leading in digital medicine and identifying new ways to utilize technology to help consumers. Through successive phases, the two companies will collaborate as Otsuka utilizes Science 37’s Metasite model to engage directly with trial . . .